Vivani Medical Inc (NAS:VANI)
$ 1.27 0 (0%) Market Cap: 70.17 Mil Enterprise Value: 64.74 Mil PE Ratio: 0 PB Ratio: 2.92 GF Score: 21/100

Vivani Medical Inc at ThinkEquity Conference Transcript

Oct 26, 2022 / 03:00PM GMT
Release Date Price: $1.9 (+1.06%)
Adam Mendelsohn
Vivani Medical, Inc. - CEO

All right. Well, good morning, everyone. Thank you for being here. I'm excited to share the Vivani Medical story with all of you who are here.

Vivani Medical is a company that is a result of a reverse merger. That a privately held company, Nano Precision Medical, which is a company that I co-founded and have been operating since 2011, went through a reverse merger with Second Sight Medical Products, which is a company that has been publicly traded for a number of years, with Nano Precision Medical being the surviving company, and the company rebranding to become Vivani Medical.

I have here -- I can pass this around. This is the device that we're making -- here, you want to take this? This device is being designed to provide six months of guaranteed adherence for a Type 2 diabetes therapy that we're preparing for a Phase 2 clinical trial. We're very excited about our prospects and what we're working on.

And the main challenge that we're addressing, which is people not taking their medicine, is something that I want to make sure people

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot